Fairchem Organics Credit Rating

Fairchem Organics Earnings Call Transcript: Key Takeaways

Fairchem reported strong Q2 growth driven by lower raw material costs and reduced Chinese dumping.

Fairchem Organics Investor Presentation: Key Takeaways

Fairchem reported strong Q2FY27 results with 49.7% YoY revenue growth and 316.7% EBITDA growth. Strategy focuses on high-value oleo chemicals, export expansion, and waste-to-wealth manufacturing using renewable resources.

Call

Guides 25% growth

Fairchem Organics Q2 FY27 Results: Net Profit ₹10.2 Cr, Up 1175.0% YoY

Fairchem Organics Ltd reported revenue from operations of ₹166.9 Cr (+49.7% YoY) and net profit of ₹10.2 Cr (+1175.0% YoY) for Q2 FY27.

Key figure

Net profit ₹10.2 Cr · +1175.0% YoY

Fairchem Organics Board Meeting Date

Fairchem Organics Limited has scheduled a board meeting for October 22, 2026, to consider and approve the unaudited financial results for the quarter ending September 30, 2026.

Fairchem Organics Other Announcement

Fairchem Organics Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.

Fairchem Organics Earnings Call Transcript: Key Takeaways

Fairchem Organics shows a recovery in Q1 FY27, driven by higher price realizations and reduced Chinese dumping, though margins remain vulnerable to external geopolitical factors and raw material volatility.

Call

Guides 20% growth

Singer India Credit Rating

Singer India's Rs.45 Crore bank facilities were re-rated by CRISIL. Long-term stayed BBB-/Stable while the short-term rating was upgraded to Crisil A3+.

Bondada Engineering Credit Rating

CRISIL upgraded credit ratings for five subsidiaries of Bondada Engineering to A/Stable or A-/Stable. The upgrade reflects strong financials and supports the group's lender credibility.

20 Microns Credit Rating

CRISIL reaffirmed 20 Microns' bank loan ratings at A/Stable and A1 on ₹117 crore facilities. Ratings remain unchanged from prior assessment.

Epigral Credit Rating

CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.

Mankind Pharma Credit Rating

CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.

Lloyds Metals & Energy Credit Rating

Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.